Please use this identifier to cite or link to this item:

TitleNovel strategies for cancer treatment: drug delivery combining graphene quantum dots and core-filled lipid vesicles
Author(s)Mendes, Rita
Soares, T.
Fernandes, Eduarda
Gonçalves, Hugo
Alves, Luis
Carvalho, Ana
Araújo, Francisca
Neves, José das
Sarmento, Bruno
Cerqueira, M. F.
Alpuim, P.
Real Oliveira, M. Elisabete C.D.
Lúcio, M.
Issue date3-Jul-2017
Abstract(s)[Excerpt] Cancer remains a global health problem and according to the International Agency for Research on Cancer, the incidence of all cancer cases will raise from 12.7 million new cases in 2008 to 21.2 million by 20301 . Doxorubicin (DOX) is considered one of the main “first-line” anticancer drugs. However, besides being a wide-spectrum antitumor drug its clinical application is limited as it is often associated with serious and generalized toxicity, development of drug resistence and low therapeutic efficiency.2 Accordingly,our research focuses in obtaining a smart nanosystem to delivery DOX to cancer cells more efficiently and with less toxicity. In view to this, we developed an all-for-one strategy, consisting on the development of two different nanocarriers loaded with doxurrubicin: DODAB:MO (1:2) formulations and graphene quantum dots (GQD) that we aim to combine in a hybrid smart nanosystem for cancer therapy.[...]
TypeConference paper
AccessRestricted access (UMinho)
Appears in Collections:CDF - FAMO - Comunicações/Communications (with refereeing)

Files in This Item:
File Description SizeFormat 
Abstrat GODots-NANAX2017.pdf
  Restricted access
200,64 kBAdobe PDFView/Open    Request a copy!

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID